Brown Brothers Harriman & Co’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$98.1K Buy
203
+67
+49% +$17.8K ﹤0.01% 993
2026
Q1
$14.9K Hold
136
﹤0.01% 1279
2025
Q4
$22.6K Hold
136
﹤0.01% 1184
2025
Q3
$26.6K Hold
136
﹤0.01% 1118
2025
Q2
$12.3K Sell
136
-49
-26% -$3.87K ﹤0.01% 1167
2025
Q1
$11K Hold
185
﹤0.01% 1054
2024
Q4
$24.5K Sell
185
-62
-25% -$5.82K ﹤0.01% 989
2024
Q3
$12.9K Buy
247
+167
+209% +$7.84K ﹤0.01% 1002
2024
Q2
$4.84K Buy
+80
New +$5.55K ﹤0.01% 1028

Other funds holding ALAB

Brown Brothers Harriman & Co's ALAB Position: Q2 2026 in Review

Brown Brothers Harriman & Co increased its Astera Labs (ALAB) stake by 49% in Q2 2026, buying an estimated $17.8K and bringing the position to 203 shares worth $98.1K. The position accounts for ﹤0.01% of the portfolio, ranked #993.

Brown Brothers Harriman & Co first reported a position in ALAB in Q2 2024 and has held it in 9 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Brown Brothers Harriman & Co held 203 shares of Astera Labs worth $98.1K as of Q2 2026.
  • Brown Brothers Harriman & Co bought 67 Astera Labs shares in Q2 2026, an estimated $17.8K.
  • Astera Labs made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #993 holding.
  • Brown Brothers Harriman & Co first reported a position in Astera Labs in Q2 2024 and has held it in 9 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.